US 7534913
Crystalline form of nateglinide
granted A61KA61K31/16A61K31/198
Quick answer
US patent 7534913 (Crystalline form of nateglinide) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K31/16, A61K31/198, A61P, A61P3/00